Award-winning plastics injection moulding manufacturer, Boddingtons, celebrates a successful Interplas 2017 in which the company has already clinched a number of new business prospects with more to follow over the coming weeks.
Managing Director Andy Tibbs was present throughout the three-day exhibition. ‘In some ways the Interplas show represents the fruit of our company’s marketing activities over the past 18 months: New customers immediately sought us out at the NEC, already equipped with drawings, specifications and, in some cases, NDA agreements for us to sign.
‘In addition,’ adds Tibbs, ‘the general footfall was impressive and the overall standard of informed enquiry was very high. Day three is not yet done and we are delighted with our Interplas 17 outcomes thus far.’
Boddingtons also presented a brand new company stand design at the NEC show, one that will now make its way to the Medica Compamed show in Düsseldorf, November 13-16. ‘Our corporate identity, presentation and communications work continues to encourage us with positive comments – not least from our Interplas visitors this week.
There is no doubt that the company’s new £4.3 injection moulding facility in Marden Kent – complete with Class 7 Clean Room and matching regulatory services – has played a key role in attracting business. ‘It’s very simple,’ says Tibbs. ‘International med-tech OEMs and specifiers want to know if you have Class 7 production facilities and services or not. If the former – then the way forward is open for business discussions.’
Boddingtons new plant was formally opened on November 1st last year by Lord Digby Jones who praised the vision and commitment of Boddingtons and the company’s investment in ‘these amazing new manufacturing facilities.’
The Class 7 Clean Rooms are now equipped with a total of eight moulding machines, beside the press automation, in line printing and other technical services, all producing a great variety of med-tech parts; from DNA trays to needle holders, endoscopy products, medical tubing and many other med-tech devices.
Boddingtons client and contract moulding services in all markets range from conceptual design, prototyping, tooling, automation and full manufacture together with the added benefit of the company having its own dedicated Regulatory Manager on site.
All manufacturing programmes at Boddingtons come on line through the company’s gated New Production Introduction (NPI) process. This helps ensure that the customer’s financial and timeline risks are minimized.
Capital investment at the company is being matched by full-scale training in lean manufacturing techniques. A pilot class of six individuals from various Boddingtons departments began the training in November 2016 and will complete later this year, applying the new skills to various in-house projects.